Extendicare (EXE.TO) Stock Price
Extendicare Price
Revenue at Extendicare has contracted by 0.3% per year over the past 19 years to 1.66 B CAD. Earnings per share have grown at 0.9% per year over the last 18 years. For Extendicare, the net margin of 5.8% is up versus 1.0% a few years ago. At today's price the dividend yield works out to roughly 1.59%. The payout ratio is around 46% of earnings. The dividend has grown at 1.4% per year over the past 19 years. The consensus 12-month price target for Extendicare is 24.48 CAD, about 22.2% below where the stock trades today. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 116% above its 52-week low.
Extendicare stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Extendicare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Extendicare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Extendicare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Extendicare Price |
|---|---|
| 9/25/2026 | 31.47 CAD |
| 9/24/2026 | 31.47 CAD |
| 9/23/2026 | 31.90 CAD |
| 9/22/2026 | 31.54 CAD |
| 9/21/2026 | 31.01 CAD |
| 9/18/2026 | 30.77 CAD |
| 9/17/2026 | 30.55 CAD |
| 9/16/2026 | 31.00 CAD |
| 9/15/2026 | 30.92 CAD |
| 9/14/2026 | 31.14 CAD |
| 9/13/2026 | 31.20 CAD |
| 9/11/2026 | 31.31 CAD |
| 9/10/2026 | 31.01 CAD |
| 9/9/2026 | 30.95 CAD |
| 9/8/2026 | 31.18 CAD |
| 9/4/2026 | 31.10 CAD |
| 9/3/2026 | 31.16 CAD |
| 9/2/2026 | 29.84 CAD |
| 9/1/2026 | 29.77 CAD |
| 8/31/2026 | 30.58 CAD |
| 8/30/2026 | 31.19 CAD |
| 8/28/2026 | 31.31 CAD |
| 8/27/2026 | 31.45 CAD |
| 8/26/2026 | 31.68 CAD |
| 8/25/2026 | 31.70 CAD |
| 8/24/2026 | 30.57 CAD |
| 8/21/2026 | 30.36 CAD |
| 8/20/2026 | 30.55 CAD |
| 8/19/2026 | 31.63 CAD |
| 8/18/2026 | 32.28 CAD |
Extendicare Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Extendicare Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB CAD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB CAD |
| EBITM CAD |
| EBIT MARGIN% |
| NET INCOMEM CAD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.CAD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.78 | 0.82 | 0.94 | 1.06 | 1.10 | 1.12 | 1.13 | 1.10 | 1.17 | 1.22 | 1.30 | 1.47 | 1.66 | 2.31 | 2.55 | 2.61 |
| -61.56 | 4.21 | 15.56 | 12.41 | 3.49 | 2.10 | 0.98 | -2.48 | 5.71 | 4.72 | 6.80 | 12.42 | 13.23 | 38.98 | 10.40 | 2.55 |
| 13.54 | 13.24 | 9.65 | 12.26 | 9.48 | 8.75 | 8.22 | 18.22 | 9.86 | 6.22 | 12.81 | 11.39 | 11.99 | 11.99 | 11.99 | 11.99 |
| 0.11 | 0.11 | 0.09 | 0.13 | 0.10 | 0.10 | 0.09 | 0.20 | 0.12 | 0.08 | 0.17 | 0.17 | 0.20 | 0.28 | 0.31 | 0.31 |
| 45.00 | 47.00 | 83.00 | 57.00 | 66.00 | 38.00 | 52.00 | 93.00 | 49.00 | 20.00 | 62.00 | 126.00 | 138.00 | 231.00 | 266.00 | 287.00 |
| 5.75 | 5.76 | 8.80 | 5.38 | 6.02 | 3.39 | 4.60 | 8.43 | 4.20 | 1.64 | 4.75 | 8.59 | 8.31 | 10.01 | 10.44 | 10.99 |
| 5.00 | -18.00 | 232.00 | 35.00 | 2.00 | 31.00 | 28.00 | 54.00 | 11.00 | 69.00 | 33.00 | 75.00 | 96.00 | 130.00 | 144.00 | 163.00 |
| -91.94 | -460.00 | -1,388.89 | -84.91 | -94.29 | 1,450.00 | -9.68 | 92.86 | -79.63 | 527.27 | -52.17 | 127.27 | 28.00 | 35.42 | 10.77 | 13.19 |
| 0.60 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.51 | 0.50 | 0.52 | 0.53 | 0.53 |
| -28.57 | -20.00 | – | – | – | – | – | – | – | – | – | 6.25 | -1.96 | 4.00 | 1.92 | – |
| 95.55 | 99.31 | 87.85 | 88.66 | 88.63 | 88.61 | 89.47 | 100.52 | 17.03 | 86.68 | 95.51 | 94.08 | 89.40 | 89.40 | 89.40 | 89.40 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Extendicare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Extendicare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Extendicare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Extendicare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Extendicare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Extendicare stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Extendicare Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Extendicare business model & stock analysis
Extendicare SWOT Analysis
Strengths
Extendicare Inc has established a considerable presence in the long-term care market. With a large number of facilities and a solid reputation, the company benefits from economies of scale and a loyal customer base.
Extendicare Inc offers a diverse range of services including long-term care, assisted living, and home health care. This allows the company to cater to a wider market and adapt to changing customer needs.
The company employs a skilled workforce consisting of healthcare professionals and support staff. This ensures high-quality care for patients and enhances the company's reputation in the industry.
Weaknesses
Extendicare Inc operates in a highly regulated industry. Changes in government regulations and policies can significantly impact the company's operations and financial performance.
The company relies heavily on government funding for a significant portion of its revenue. Any reduction or changes in government funding could adversely affect Extendicare Inc's financial stability.
As a provider of healthcare services, Extendicare Inc faces the risk of reputation damage if there are any significant incidents or allegations of negligence or substandard care.
Opportunities
The increasing aging population presents an opportunity for Extendicare Inc to expand its services and cater to the growing demand for long-term care and assisted living facilities.
Advancements in technology, such as remote patient monitoring and electronic health records, can improve the efficiency and quality of care provided by Extendicare Inc. Embracing these technologies can enhance the company's competitiveness.
Extendicare Inc has the opportunity to expand its operations into new markets or geographies, either through organic growth or strategic acquisitions. This can diversify the company's revenue streams and reduce its dependence on a single market.
Threats
The long-term care industry is highly competitive, with numerous providers vying for market share. Extendicare Inc faces the threat of losing customers to competitors who offer similar or better services.
The rising costs of healthcare, including labor costs and medical supplies, present a challenge for Extendicare Inc. The company needs to effectively manage these costs to maintain profitability.
Economic instability, including recessions or financial crises, can affect the demand for long-term care services. Extendicare Inc needs to anticipate and adapt to changes in the economic environment to mitigate potential risks.
Extendicare Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Extendicare historical P/E ratio, EBIT multiple, and P/S ratio
Extendicare annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Extendicare's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Extendicare's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Extendicare's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Extendicare shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Extendicare stock splits
Since 2012, a total of 1 shares have been converted from one Extendicare share.
Extendicare Dividend History
25 years of dividend payments
Extendicare dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Extendicare dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Extendicare forecasts and price targets in September 2026
Analyst Price Targets 2026Extendicare Analyst Rating Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| 3/11/2024 | Maintained | Hold |
Extendicare Earnings Calls
Extendicare Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 11/11/2026 | 0.36CAD | - | 600.57 MCAD | - | 2026 Q3 |
| 8/6/2026 | 0.39CAD | 0.31CAD | 567.22 MCAD | - | 2026 Q2 |
| 5/7/2026 | 0.21CAD | 0.42CAD | 437.40 MCAD | - | 2026 Q1 |
| 2/26/2026 | 0.26CAD | 0.29CAD | 485.52 MCAD | - | 2025 Q4 |
| 11/11/2025 | 0.20CAD | 0.28CAD | 417.15 MCAD | - | 2025 Q3 |
| 8/6/2025 | 0.18CAD | 0.37CAD | 415.35 MCAD | - | 2025 Q2 |
| 5/6/2025 | 0.16CAD | 0.18CAD | 427.60 MCAD | - | 2025 Q1 |
| 2/27/2025 | 0.18CAD | 0.23CAD | 371.92 MCAD | - | 2024 Q4 |
| 11/12/2024 | -CAD | 0.19CAD | 378.25 MCAD | - | 2024 Q3 |
| 8/12/2024 | -CAD | 0.27CAD | 346.75 MCAD | - | 2024 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Extendicare stock
EEnvironment
Environment
SSocial
Social
GGovernance (Corporate Governance)
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Extendicare shareholder structure
| % | Name |
|---|---|
10.87647% | |
9.56995% | |
6.22679% | |
1.20967% | |
1.17645% | |
1.04326% |
Extendicare Beneficial Ownership Filings (SEC 13D/G)
Extendicare Executives and Management Board
18 members · avg. age 65 · 44 % women
Dr. Michael Guerriere (61)
President, Chief Executive Officer, Director · since 2018
2.20 M CAD
Management
Mr. David Bacon
Chief Financial Officer, Executive Vice President
Mr. John Toffoletto
Senior Vice President, Chief Legal Officer and Corporate Secretary
Mr. Steve Paraskevopoulos
Senior Vice President - ParaMed and Chief Technology Officer
Dr. Matthew Morgan
Chief Medical Officer
Ms. Jillian Fountain
Vice President of Investor Relations
Ms. Katie Lemoyne
Chief Human Resources Officer, Senior Vice President
Board of Directors
Mr. Alan Torrie (74)
Independent Chairman of the Board
Mr. Brent Houlden (71)
Independent Director
Ms. Donna Kingelin (69)
Independent Director
Ms. Sandra Hanington (63)
Independent Director
Mr. Samir Manji (56)
Independent Director
Ms. Norma Beauchamp (63)
Independent Director
Extendicare Supply Chain
Extendicare Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.64 | 0.33 | 0.81 |
Frequently asked questions about Extendicare
The business model of Extendicare Inc. is focused on providing long-term care and healthcare services to seniors in Canada. Extendicare operates a network of retirement and long-term care facilities, offering a range of services such as nursing care, assisted living, memory care, and rehabilitative therapies. The company also provides home healthcare services, including nursing, personal care, and therapy services for individuals living in their own homes. With a commitment to quality care and a person-centered approach, Extendicare aims to enhance the health and well-being of the seniors it serves.
Extendicare Inc is primarily active in the healthcare industry.
The main competitors of Extendicare Inc in the market are Revera Inc and Sienna Senior Living Inc.
Extendicare Inc is a leading provider of healthcare services in North America, specializing in long-term care. Established in 1968, Extendicare has grown to become a trusted name in the industry. With a focus on enhancing the quality of life for individuals in its care, Extendicare operates a network of senior care and retirement living centers across Canada and the United States. The company's commitment to delivering personalized and compassionate care has earned it a strong reputation among its clients and stakeholders. Over the years, Extendicare has consistently demonstrated its dedication to excellence, making it a preferred choice in the healthcare sector.
Extendicare Inc has achieved several significant milestones throughout its history. In recent years, the company successfully expanded its reach and diversified its portfolio through strategic acquisitions and partnerships. Notably, Extendicare has been recognized as one of Canada's leading providers of senior care and retirement living solutions. Additionally, the company has continually focused on enhancing its healthcare services, prioritizing quality care, and implementing innovative practices. Extendicare's commitment to delivering exceptional senior care has earned it a strong reputation in the industry.
Extendicare Inc is primarily present in Canada.
Extendicare Inc represents a commitment to providing high-quality senior care services. With a focus on nurturing and enhancing the lives of seniors, their corporate philosophy centers around compassion, respect, and dignity. Extendicare understands the importance of personalized care, ensuring physical, emotional, and social well-being of residents. By leveraging their expertise, experience, and dedication, Extendicare strives to deliver exceptional care and improve the quality of life for seniors. As a leading provider of long-term care and retirement living options, Extendicare's values revolve around compassion, integrity, accountability, and teamwork, making them a trusted name in the senior care industry.
Analysts currently set an average price target of 24.43 CAD for the Extendicare stock (median: 24.48 CAD), implying -22.4 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Extendicare stock: 8 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Extendicare to generate revenue of 2.31 B CAD and earnings per share of 1.46 CAD.
Converted at the current exchange rate, the Extendicare share trades at 19.54 EUR (31.47 CAD).
The Extendicare share (EXE.TO) is listed on 5 stock exchanges, including: London (0S9E.L), Toronto (EXE.TO), Frankfurt (5XE.F), München (5XE.MU).
Extendicare Inc is a leading senior and long-term care company from Canada with over 120 facilities in North America, offering a wide range of services for patients of all ages. The company is headquartered in Markham, Ontario, and was founded in 1968. Extendicare's business model is to provide a wide range of facilities and services for people of all ages in need of medical care, rehabilitation, and long-term care. The company is divided into two business segments: Extendicare Health Services and Extendicare Assist. Extendicare Health Services primarily offers long-term care facilities, rehabilitation clinics, and other healthcare facilities. They also provide a variety of clinical services such as physiotherapy, occupational therapy, speech therapy, wound management, diagnostics, and other clinical services. The portfolio also includes assisted living residences and skilled nursing facilities that specialize in specific needs such as Alzheimer's and dementia. Extendicare Assist is a branch of the company specializing in providing care services and support services. These facilities offer specialized care and support for patients who want to be cared for at home while also receiving proper medical supervision. Services offered include homemaking support, palliative care and hospice care, rehabilitation support, and day programs. Extendicare offers a wide range of products and services tailored to the different needs of its customers. The facilities are designed to accommodate both individuals and groups of patients with different needs. Some of the products offered by Extendicare include: 1. Long-term care offerings - care facilities that offer a wide range of clinical services. 2. Rehabilitation clinics - facilities that offer specialized rehabilitation programs for patients with physical disabilities or injuries. 3. Assisted living - residences that offer senior-friendly apartments and services. 4. Hospice care requirements - a facility for caring for patients in the final stage of life. 5. Senior day programs and patient rehabilitation programs - programs designed to provide patients with care and rehabilitation services during the week but still allow them to return to their own homes. In recent years, Extendicare has also enhanced its services to meet the needs of an aging population. It has focused on developing technologies that simplify care for patients and their caregivers at home. One of Extendicare's recent developments is the Intouch Monitoring System, which allows caregivers to monitor the condition of patients in real-time. Overall, Extendicare is a leading provider of senior and long-term care services, focusing on the needs of patients of all ages. With its wide range of services, technologies, and facilities, it is well-positioned to respond to the needs of an aging population and provide high-quality care.
The expected revenue of Extendicare is 2.31 B CAD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Extendicare is 130.92 M CAD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Extendicare is currently 21.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Extendicare stock.
The price-to-sales ratio (P/S) of Extendicare is currently 1.22. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Extendicare stock.
The Eulerpool Quality Score for Extendicare is 7/10.
The ISIN of Extendicare is CA30224T8639. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Extendicare is A1JZ4L. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Extendicare is EXE.TO. The ticker symbol is used to trade Extendicare shares on the stock exchange.
Over the past 12 months, Extendicare paid a dividend of 0.50 CAD . This corresponds to a dividend yield of about 1.59 %. For the coming 12 months, Extendicare is expected to pay a dividend of 0.53 CAD.
The current dividend yield of Extendicare is 1.59 %.
Extendicare pays a dividend, distributed in the months of May, June, July, August.
Extendicare paid dividends every year for the past 21 years.
For the upcoming 12 months, dividends amounting to 0.53 CAD are expected. This corresponds to a dividend yield of 1.67 %.
Extendicare is assigned to the 'Health' sector.
In the year 2025, Extendicare distributed 0.5 CAD as dividends.
The dividends of Extendicare are distributed in CAD.
Extendicare stock
Extendicare Peer Group
Extendicare Ticker
Extendicare FIGI
All fundamentals and in-depth analysis of Extendicare
Our stock analysis for Extendicare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Extendicare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.